2017 Annual Post-Meeting Edition

  • AAD delivers one of its strongest Annual Meetings in OrlandoOrlando is a city that is invariably associated with “magic.” Add to that magic some stellar scientific sessions, speakers, and events, and you create a special event that is truly spellbinding. It was an experience not soon to be forgotten by attendees who assembled in Florida for the 2017 AAD Annual Meeting, March 3-7, at the Orange County Convention Center. > MORE
  • Aggressive treatment needed for hidradenitis suppurativaHidradenitis suppurativa (HS) is a plague for patients but an area ripe for dermatologic researchers. Treatment advances such as biologics and more effective surgical techniques are improving patient outcomes, but there have been almost no randomized controlled trials in HS. > MORE
  • Adults with atopic dermatitis are not just big kidsMany clinicians think of atopic dermatitis (AD) as a childhood disease. Even dermatologists may not realize that the prevalence of AD in adults is only slightly lower than in children. The difference is about 10 percent in adults versus 12 percent in children. > MORE
  • Start early to forestall cosmetic effects of agingAn aging body is like aging machinery; it doesn’t break down overnight but wears down gradually. This has led a growing number of people to begin maintenance cosmeceutical treatments before the aging process sets in. > MORE
  • PDT effective in medical and cosmetic usesPhotodynamic therapy (PDT) is emerging as a useful tool in medical and cosmetic dermatology. The target is the same for skin damaged by the sun and other environmental insults. These actinic keratoses (AK) are precursors to skin cancer that degrade the texture and appearance of the skin. > MORE
  • Advances in psoriasis treatments, research examinedClinicians and researchers have targeted psoriasis in recent years, leading to the development of many new treatments. Advances include the development of biologics, learning about the effect of biologics and psoriasis on vascular inflammation, and genetic links between psoriasis and autoimmune disorders. However, challenges, such as the high cost of biologics and biosimilars, have slowed progress. > MORE
  • Nonsurgical options increasing for skin cancersSurgery was once a primary option for treating nearly all skin cancers, but advancing technology is expanding treatment options. New laser applications, biologics, and other modalities are giving dermatologists more effective nonsurgical treatments of skin cancers in a growing range of patients. > MORE
  • Fox Award: The future of dermatology recognizedWinners of this year’s Everett C. Fox Memorial Award presented the most outstanding papers in basic science and clinical research March 4, during the “Resident and Fellows” symposium. The top papers were chosen by faculty judges led by Robert Dellavalle, MD, PhD. > MORE
  • Northwestern team wins Resident JeopardyA team from Northwestern University Feinberg School of Medicine won the Resident Jeopardy competition March 5. The winning team was The Derminators, whose members were Sarah Adams, PGY-4, and Kassandra Holzem, PGY-3. > MORE
  • Poster winners namedThe AAD Poster Exhibits Task Force announced the recipients of the 2017 Annual Meeting Poster Awards. > MORE